BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial.
BCMA 靶向 mRNA CAR-T 细胞疗法治疗重症肌无力：安慰剂对照 2b 期试验的探索性生物标志物分析。
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-04170-z
Fedak Renee R, Ruggerie Rachel N, Shan Yufei, Curvino Elizabeth J, de Sousa Juliana F, Daniel Shaji, Ngo-Casi Minhtran, Kamboh Hafsa, Vu Tuan, DurmuÅ Hacer, Mozaffar Tahseen, Howard James F Jr, English Emily P, Benson Albina, Duvernay Matthew T, Singer Michael S, Kalayoglu Murat V, Brunn Carsten, Bodansky Aaron, Anderson Mark S, DeRisi Joseph L, Garcia Samantha T, Yu David J L, Zorn Kelsey C, Kurtoglu Metin, MiljkoviÄ MiloÅ¡ D, Stewart C Andrew, Jewell Christopher M
